Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

BACKGROUND: Primary retroperitoneal lymph node dissection (RPLND) ultimately lost its role as the standard management of clinical stage (CS) 1 nonseminomatous (NS) testicular germ cell tumours (GCTs) in Europe when the European Germ Cell Cancer Consensus Group released their recommendations in 2008....

Descripción completa

Detalles Bibliográficos
Autores principales: Dieckmann, K.-P., Anheuser, P., Kulejewski, M., Gehrckens, R., Feyerabend, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204050/
https://www.ncbi.nlm.nih.gov/pubmed/30367648
http://dx.doi.org/10.1186/s12894-018-0412-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204050/
https://www.ncbi.nlm.nih.gov/pubmed/30367648
http://dx.doi.org/10.1186/s12894-018-0412-x

Ejemplares similares